Pustular psoriasis. Photo by Roland Tanglao via Wikimedia Commons Cutaneous paradoxical reactions to biologic therapies for psoriasis and atopic dermatitis are emerging as an important, if unpredictable, complication of these otherwise highly targeted treatments, according to Dr. Jeffrey Marcus Cohen . In a report in the Dec. 2025 issue of The Chronicle of Skin & Allergy , Dr. Cohen noted monoclonal antibodies have transformed care by addressing the underlying immunology of c

Mycosis fungoides. Photo by: Bobjgalindo via Wikimedia Commons A fusion protein therapy may be an effective treatment option for...

A study published in the journal Blood raises concerns about current diagnostic guidelines for cutaneous T-cell lymphomas (CTCLs)....